BigBear.ai's stock has declined by roughly 25% in the previous month.
1 extracted signal · 1 resolved · 0 still active
Parkev Tatevosian, CFAIndependent analyst profile- Source published
- 23 Aug 2025, 23:45 UTC
- Recorded by Tahlil Plus
- 18 May 2026, 20:23 UTC

AI-generated source summary
The analysis reviews BigBear.ai's stock performance, noting a 25% decrease in the last month. Despite long-term potential, the stock is currently overvalued. The analyst cites the One Big Beautiful Bill as a potential catalyst, allocating $170B to Homeland Security and $150B to Department of Defense for disruptive defense technology, benefiting BigBear.ai. However, the most recent quarter saw the loss of government contracts due to government efficiency efforts, partnering Elon Musk and Donald Trump in a cost-cutting effort. BigBear.ai biometric traveler processing solutions are deployed in over 2000 devices across 500 gates and 25 airports. The management team announced $390 million cash to support new growth with urgency, but took about a $75 million goodwill impairment in the current quarter on previous investments, valuing the stock at $1.96, against a current $5.49 market price.
AI-generated summary based on the source content.
Signal outcomes at a glance
Evaluation CompleteSignals in this source
Evidence and evaluation progress
- Original source published
The analyst published the original source item.
- First prediction resolved
The first evaluable outcome in this case reached a terminal result.
- Case evaluation completed
All evaluable predictions in this case reached terminal outcomes.
- Source recorded by Tahlil Plus
The public source was preserved as the evidence record for this case.
- Market predictions extracted
1 eligible signal linked to this case.
- Outcome tracking started
Tahlil Plus began monitoring the extracted predictions.
Parkev Tatevosian, CFA
Platform-wide history, separate from this source evaluation.
Tahlil Plus independently records and evaluates public market predictions. Extraction may be AI-assisted and results follow the Tahlil Plus methodology. This information is not financial advice.
